Trelegy ellipta 200-62.5-25 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F9V88
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,132
Award facts
- Contract value 100% obligated
- $10,132.17 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $10,132.17 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 9, 2026, for the supply of TRELEGY ELLIPTA 200-62.5-25 (60-count units), a combination inhalation powder used in the treatment of chronic obstructive pulmonary disease. This is a competitive, non-set-aside award with an ultimate completion date of January 12, 2026, and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary pharmaceutical supply vehicle for military healthcare programs globally.
AmerisourceBergen, through its parent Cencora, Inc., is one of the nation's largest pharmaceutical distributors and supplies critical medications and medical commodities across multiple therapeutic domains to federal agencies including the Defense Health Agency and U.S. Coast Guard. This delivery order represents a routine task order for specialty respiratory medication in support of military healthcare operations worldwide. The company's extensive federal contract portfolio and established relationship with DLA demonstrate its capability to efficiently fulfill government pharmaceutical procurement requirements on a competitive basis.
Quick answers
Who was awarded contract SPE2DR26F9V88?
SPE2DR26F9V88 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 9, 2026.
How much is contract SPE2DR26F9V88 worth?
The government has obligated $10,132 on SPE2DR26F9V88.
Is contract SPE2DR26F9V88 an order under another contract?
Yes. SPE2DR26F9V88 is a delivery order under SPE2DR25D3103, an indefinite delivery contract.
Was contract SPE2DR26F9V88 competed?
The extent of competition for SPE2DR26F9V88 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award